Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2101203	重组抗VEGFR2全人源单克隆抗体注射液	Recombinant anti-VEGFR2 human monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2021-07-19		Beijing Dongfang Biotech Co Ltd			view
CXSL1700064	重组抗VEGFR2全人单克隆抗体注射液	Recombinant anti-VEGFR2 human monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2017-07-13	上海复宏汉霖生物技术股份有限公司	Shanghai Henlius Biotech Co Ltd	Certificate Issued	2018-01-17	view
CXSL1600119	重组抗VEGFR2全人源单克隆抗体注射液	Recombinant anti-VEGFR2 human monoclonal antibody	Injection	Biological Products(2)	New Drug Application	2017-01-26	四川科伦博泰生物医药股份有限公司	Sichuan Kelun-Biotech Biopharmaceutical Co Ltd	Certificate Issued	2018-03-20	view
CXSL1800113	重组抗VEGFR2全人单克隆抗体注射液	Recombinant anti-VEGFR2 human monoclonal antibody	Injection	Biological Products(2)	New Drug Application	2018-11-14	齐鲁制药有限公司	QILU Pharmaceutical Co Ltd	In Review	2018-11-12	view
CXSB2000009	重组抗VEGFR2全人源单克隆抗体注射液	Recombinant anti-VEGFR2 human monoclonal antibody	Injection	Biological Products	Supplementary Application	2020-04-23	四川科伦博泰生物医药股份有限公司	Sichuan Kelun-Biotech Biopharmaceutical Co Ltd	In Review	2020-04-22	view